We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease. A randomized, controlled trial.
- Authors
Badesch, D B; Tapson, V F; McGoon, M D; Brundage, B H; Rubin, L J; Wigley, F M; Rich, S; Barst, R J; Barrett, P S; Kral, K M; Jöbsis, M M; Loyd, J E; Murali, S; Frost, A; Girgis, R; Bourge, R C; Ralph, D D; Elliott, C G; Hill, N S; Langleben, D; Schilz, R J; McLaughlin, V V; Robbins, I M; Groves, B M; Shapiro, S; Medsger, T A, Jr
- Abstract
Pulmonary hypertension is a progressive and often fatal complication of the scleroderma spectrum of disease for which no treatment has been proven effective in a randomized trial.
- Publication
Annals of internal medicine, 2000, Vol 132, Issue 6, p425
- ISSN
0003-4819
- Publication type
Journal Article
- DOI
10.7326/0003-4819-132-6-200003210-00002